Navigation Links
BD Biosciences Introduces New Device Designed to Increase Cell Growth and Cell Culture Productivity
Date:9/27/2011

BILLERICA, Mass., Sept. 27, 2011 /PRNewswire/ -- BD Biosciences, a segment of BD (Becton, Dickinson and Company), announced today the availability of the new BD Falcon™ Multi-Flask, a multi-layer cell culture device that will allow researchers to scale-up their cell culture easily and more efficiently.

Currently, most expansion of attachment-dependent cells occurs in single-layer flasks. The new BD Falcon Multi-Flask, available in both three- and five-layer designs (525 and 875 cm squared), simplifies cell culture scale-up by providing the same footprint, reagent volumes, and cell seeding densities per unit area as single-layer flasks but with three to five times more cell growth. The BD Falcon Multi-Flask also has the same proven tissue culture surface treatment as all other BD Falcon Flasks.

"The BD Falcon Multi-Flask will address the needs of researchers to grow more cells faster and more efficiently without compromising the quality of the cell culture," said Ken Linehan, Product Manager, BD Biosciences – Discovery Labware. "The BD Falcon Multi-Flask's pipet access and in-vessel mixing provide the convenience of a standard flask with the increased capacity of a multi-layer flask."

In addition to simplifying scale-up, the BD Falcon Multi-Flask features a mixing port that allows cells and media to be mixed inside the flask. This mixing process eliminates multiple steps from the cell culture workflow and reduces the risk of contamination.  Cells and media can be aspirated within the vessel using a pipet, which also eliminates steps and reduces contamination risks.

The BD Falcon Multi-Flask provides for a uniform distribution of media and cells to facilitate homogeneous cell growth on all layers. This uniform distribution of cells, combined with effective gas exchange and the Multi-Flask's proven vacuum gas tissue culture surface treatment, provides high cell yields and an ideal cell culture environment.

About BD

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.

Contact:
Jamie Yacco
Public Relations
(201) 847-4796
Jamie_Yacco@bd.com


'/>"/>
SOURCE BD-Becton Dickinson
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Neurocrine Biosciences Announces Elagolix Scientific Presentations at the 67th Annual Meeting of the American Society for Reproductive Medicine
2. Sangamo BioSciences Announces Presentation at the Sixth Annual JMP Securities Healthcare Conference
3. Regado Biosciences to Present at the Annual UBS Global Life Sciences Conference in New York City
4. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
5. Neurocrine Biosciences Announces the Start of Phase II Study of Elagolix in Uterine Fibroids
6. Coronado Biosciences to Present at the Rodman & Renshaw Annual Global Investment Conference
7. Neurocrine Biosciences To Present at the Stifel Nicolaus 2011 Healthcare Conference
8. Alzheimers Drug Discovery Foundation Supports Madera Biosciences with a Grant to Advance Novel Drug Candidates for Alzheimers Disease
9. Ardea Biosciences to Present at Wedbush Securities Life Sciences Conference
10. Neurocrine Biosciences Announces Conference Call and Webcast to Present Second Quarter 2011 Financial Results
11. Magellan Biosciences Sells TREK Microbiology Business to Thermo Fisher Scientific
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... SAN DIEGO , Dec. 9, 2016 /PRNewswire/ ... with Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ... program targeting ,LpxC, for the treatment of bacterial ... LpxC has been recognized as an attractive antibacterial ... however, a lack of suitable chemical starting points ...
(Date:12/8/2016)... LONDON , Dec. 8, 2016 ... Summary GlobalData,s new report, "Australia Glaucoma ... market data on the Australia Glaucoma Surgery Devices ... US dollars, volume (in units) and average prices ... The report also provides company shares and ...
(Date:12/8/2016)... -- Global Interventional Radiology Market: Scope and Methodology ... market analyzes the current and future prospects of ... summary, including a market snapshot that provides overall ... research is a combination of primary and secondary ... research efforts along with information collected from telephonic ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... ... its 10th anniversary with the grand opening of the Sober College Robert Pfeifer ... spanned two days, December 2-3, and was attended by an overwhelming amount of ...
(Date:12/9/2016)... , ... December 09, 2016 , ... ... at The Pierre Hotel in New York, NY, on December 3rd, to benefit ... and physicians attended the annual event, which raised over $1 million - the ...
(Date:12/9/2016)... ... December 09, 2016 , ... The Pennsylvania Athletic Trainers’ Society ... the summer of 2016. The program was made possible by a Pennsylvania Department ... of Health and Human Services Administration. The broadcast, Use Your Head: Properly ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Institute (WCRI) officially opened registration today for its 33rd Annual Issues & ... MA . , The theme of the conference is “Persistent Challenges and New ...
(Date:12/8/2016)... ... December 08, 2016 , ... Seavest ... Property owned by an affiliate of Seavest, has won a prestigious national healthcare ... Chester County ambulatory care center (ACC) was named “Best New Development, MOBs and ...
Breaking Medicine News(10 mins):